Tenn.-based Reimagine Care Secures an Investment from Oncology Ventures, a cancer-focused venture capital fund. This investment marks a significant milestone in the combined pursuit of innovative and patient-centric approaches to cancer care delivery.
Read also – CA-based Hyperlink Ventures Secures it’s First fund at $32M
Oncology Ventures, renowned for its commitment to advancing oncology care and patient outcomes, recognizes the transformative potential of Reimagine Care.
The investment will facilitate the development and expansion of Reimagine Care’s product development and commercial acceleration.
Read also – ME-based Biochar Producer Standard Biocarbon Secures $5M in Funding
Dan Nardi, CEO of Reimagine Care said, “We are excited and honored to share the news of this investment from Oncology Ventures, an organization that joins in our commitment to pushing the boundaries of healthcare innovation, This collaboration aligns with our goal of seeking out partners that prioritize the well-being of patients, including accessibility and overall satisfaction of care. We believe this investment will make a meaningful impact on the way cancer care is experienced, from both a patient and a physician perspective.”
Ben Freeberg, Founder and Managing Partner of Oncology Ventures shares, “Reimagine Care aligns perfectly with Oncology Ventures’ thesis on better utilizing data and technology to improve patient outcomes and experience, while reducing costs for key industry stakeholders. We are excited to partner with Dan and the Reimagine Care team as they continue to work with leading institutions, like City of Hope and The Center for Cancer and Blood Disorders, and additional strategics, helping to provide true value-based care.”
Reimagine Care is at the forefront of leveraging technology and data-driven insights to create highly efficient and personalized healthcare solutions.
Read also – CA-based Vasa Therapeutics Secures a Seed Funding
By combining Oncology Venture’s commitment to the advancement of healthcare through innovative technologies with Reimagine Care’s visionary approach to cancer care delivery, this partnership aims to drive meaningful change in the industry.
About Reimagine Care
They believe people living with cancer deserve a better patient experience; to feel their best and to spend as much time as possible with the people they love, doing the things that bring them joy.
Read also – NJ-based Cosette Pharmaceutical Acquired Vyleesi®
Reimagine Care integrates clinical oncology experts and robust, enabling technologies to deliver a high-touch, individualized cancer treatment and recovery experience from home. This holistic approach relies on the combination of empathy and knowledge of their clinical care team with their thoughtfully designed and easy-to-use platform.
